Lilly Rebates Prompt U.S. Attorney Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
The Philadelphia U.S. Attorney’s office is investigating Medicaid best price reporting for Zyprexa and several other Lilly products.